New Announcement from PPTA

Plasma Protein Therapeutics Association Issues Statement on Plasma Supply


The Plasma Proteins Therapeutic Association recently released a statement about the effect of the COVID-19 pandemic on source plasma donations and the critical need for plasma donations.  

There is an urgent need for plasma donations. Reports vary, but plasma collectors experienced significant declines in collections due, in part, to the impacts of social distancing measures and other mobility restrictions caused by the COVID-19 pandemic.1,2 Considering the complex manufacturing of plasma-derived therapies can take 7-12 months, any decline in plasma donations could impact patients’ ability to access their lifesaving therapies.3,4. This sharp decline in plasma collections currently being experienced could cause more significant challenges in the months to come.

PPTA continues:

The COVID-19 pandemic has shed a light on certain barriers with the potential to impact patient access to plasma-derived therapies. PPTA continues to appeal to authorities in the U.S. to address the barriers that impede the private sector’s ability to collect plasma in certain states, and in Europe, we repeat our call for the coexistence of the private sector with the public sector to collect more plasma. These common-sense updates can be accomplished with no impact on the safety of donors or on the finished products. The same urgency for patients suffering from COVID-19 exists for those with chronic and rare diseases whose lives depend on plasma-derived therapies. 

You can read the full statement here>>

News & Updates

Get the latest information on plasma through our news and updates. Featuring: Scientific discoveries, plasma supply, industry-related coverage, policy and legislation, and more!

How plasma saved lives through the ages, from 1918 to WWII to today


Both convalescent plasma and plasma-based therapies have been around for some time, though many people are still unfamiliar with their history.
Read More

Science-based policies boost plasma donation globally


Science is driving global advancements in policy and allowing more people around the world to donate plasma while ensuring the safety of donors and the plasma collected.
Read More

How plasma-based therapies treat hemophilia


Plasma has been used to treat bleeding disorders like hemophilia since the 1950s, and is still one of the most effective treatment options for patients.
Read More

GBS, CIDP, and plasma


Guillain-Barré syndrome (GBS) and chronic inflammatory demyelinating polyneuropathy (CIDP) are rare neurological disorders and plasma-based therapies are used to treat them.
Read More

FDA proposes risk-based rules for plasma and blood donations


On January 27, 2023, the U.S. Food and Drug Administration announced a draft proposal for eligibility rules for blood and blood product donation using “gender-inclusive, individual risk-based questions to reduce the risk of transfusion-transmitted HIV.”
Read More

Stiff person syndrome and plasma


SPS is a rare and progressive neurological disease. It affects one person in a million and Celine Dion is one of those people relying on plasma donation to treat the condition.
Read More
Powered By:
Mojo Creative Digital